Cationic liposome-mediated uptake of human immunodeficiency virus type 1 Tat protein into cells

Journal of Virological Methods

Volumn 66, Issue 1, 1997, Pages 149-157

  Fong, Steven E ^a,b   Smanik, Patricia ^a,c   Smith, Michele C ^a   Jaskunas, S Richard ^a  

^a ELI LILLY AND COMPANY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Cationic; Cellular; HIV 1; Liposome; Tat; Uptake

Indexed keywords

LIPOSOME; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; REPORTER GENE; VIRUS EXPRESSION; VIRUS GENE;

BLOTTING, WESTERN; CATIONS; CHLOROQUINE; GENE PRODUCTS, TAT; HELA CELLS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LIPOSOMES; PHOSPHATIDYLETHANOLAMINES; TRANS-ACTIVATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030744354     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(97)00070-0     Document Type: Article

References (27)

1. Barillari, G., Gendelman, R., Gallo, R.C., Ensoli, B., 1993. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90, 7941-7945.
2. Burnette, W.N., 1981. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112, 195-203.
3. Calnan, B.J., Tidor, B., Biancalana, S., Hudson, D., Frankel, A.D., 1991. Arginine-mediated RNA recognition: the arginine fork. Science 252, 1167-1171.
4. Chen, W., Carbone, F.R., McCluskey, J., 1993. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. J. Immunol. Methods 160, 49-57.
5. Cordingley, M.G., LaFemina, R.L., Callahan, P.L., Condra, J.H., Sardana, V.V., Graham, D.J., Nguyen, T.M., LeGrow, K., Gotlib, L., Schlabach, A.J., Colonno, R.J., 1990. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro. Proc. Natl. Acad. Sci. USA 87, 8985-8989.
6. Dang, C.V., Lee, W.M.F., 1989. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J. Biol. Chem. 264, 18019-18023.
7. Dayton, A.I., Sodroski, J.G., Rosen, C.A., Goh, W.C., Haseltine, W.A., 1986. The trans-activator gene of the human T-cell lymphotropic virus type III is required for replication. Cell 44, 941-947.
8. DeWet, J.R., Wood, K.V., DeLuca, M., Helinski, D.R., Subramani, S., 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell Biol. 7, 725-737.
9. Dimitrov, D.S., Willey, R.L., Sato, H., Chang, L.-J., Blumenthal, R., Martin, M.A., 1993. Quantitation of human immunodeficiency virus type 1 infection kinetics. J. Virol. 67, 2182-2190.
10. Endo, S., Kubata, S., Siomi, H., Adachi, A., Oroszlan, S., Makin, M., Hatanaka, M., 1989. Trans-activation of human immunodeficiency virus type gene expression is mediated by nuclear events. Virus Genes 3, 99-110.
11. Ensoli, B., Buonaguro, L., Barillari, G., Fiorelli, V., Gendelman, R., Morgan, R.A., Wingfield, P., Gallo, R.C., 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287.
12. Feigner, J., Martin, M., Tsai, Y., Felgner, P.L., 1993. Cationic lipid-mediated transfection in mammalian cells: 'Lipofection'. J. Tissue Cult. Methods 15, 63-68.
13. Feigner, P.L., Gadek, T.R., Holm, M., Roman, R., Chan, H.W., Wenz, M., Northrop, J.P., Ringold, G.M., Danielsa, G.A., 1987. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84, 7413-7417.
14. Fisher, A.G., Feinberg, J.B., Josephs, S.F., Harper, M.E., Marselle, L.M., Reyes, G., Gonda, M.A., Aldovini, C., Debouk, C., Gallo, R.C., Wong-Staal, F., 1986. The transactivator gene of HTLV-III is essential for virus replication. Nature (London) 320, 367-371.
15. Fong, S.E., Smanik, P., Thais, T., Smith, M.C., Jaskunas, S.R., 1997. Detection of specific human immunodeficiency virus type 1 Tat-TAR complexes in the presence of mild denaturing conditions. J. Virol. Methods, 66, 91-101 (this issue).
16. Frankel, A.D., 1992. Activation of HIV transcription by Tat. Curr. Opin. Genet. Dev. 2, 293-298.
17. Frankel, A.D., Pabo, C.O., 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55, 1189-1193.
18. Gentz, R., Chen, C.-H., Rosen, C.A., 1989. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. Proc. Natl. Acad. Sci. USA 86, 821-824.
19. Kuppuswarny, M., Subramanian, T., Srinivasan, A., Chinnadurai, G., 1989. Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis. Nucleic Acids Res. 17, 3551-3561.
20. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227, 680-685.
21. Mann, D.A., Frankel, A.D., 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10, 1733-1739.
22. Ruben, S., Perkins, A., Purcell, R., Joung, K., Sia, R., Burghoff, R., Haseltine, W.A., Rosen, C.A., 1989. Structural and functional characterization of human immunodeficiency virus tat protein. J. Virol. 63, 1-8.
23. Schwartz, O., Virelizier, J.-L., Montagnier, L., Hazan, U., 1990. A microtransfection method using the luciferase-encoding reporter gene for the assay of human immunodeficiency virus LTR promoter activity. Gene 88, 197-205.
24. Siomi, H., Shida, H., Maki, M., Hatanaka, M., 1990. Effects of a highly basic region of human immunodeficiency virus Tat protein on nucleolar localization. J. Virol. 64, 1803-1807.
25. 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J. Cell Biol. 121, 461-468.
26. Walker, C., Selby, M., Erickson, A., Cataldo, D., Valensi, J.-P., Van Nest, G., 1992. Cationic lipids direct a viral glycoprotein into the class I major histocompabitility complex antigen-presentation pathway. Proc. Natl. Acad. Sci. USA 89, 7915-7918.
27. Zauli, G., La Placa, M., Vignoli, M., Re, M.C., Gibellini, D., Furlini, G., Milani, D., Marchisio, M., Mazzoni, M., Capitani, S., 1995. An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10, 306-316.